Safety and microbiological activity of phage therapy in persons with cystic fibrosis colonized with Pseudomonas aeruginosa: study protocol for a phase 1b/2, multicenter, randomized, double-blind, placebo-controlled trial
DiscussionThis trial will investigate the activity of phages in reducingP. aeruginosa colony counts and provide insights into the safety profile of phage therapy.Trial registrationClinicalTrials.gov NCT05453578. Registered on 12 July 2022. (Source: Trials)
Source: Trials - December 28, 2022 Category: Research Source Type: clinical trials
Effect of PreforPro ® on Urinary and Vaginal Health
Conditions: Bacterial Vaginosis; Bacterial Infections; Bacterial Vaginosis| Vaginal| Microbiology; Vaginal Infection Interventions: Drug: Preforpro; Other: Placebo Sponsors: Jeremy Burton; Deerland Enzymes; Lawson Health Research Institute; St. Joseph's Health Care London Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 21, 2022 Category: Research Source Type: clinical trials
